Mortality Rates and Causes of Death in Swedish Myasthenia Gravis Patients
Myasthenia Gravis (MG) is an autoimmune neuromuscular disease characterized by skeletal muscle weakness and fatigability. Disease severity and pattern of muscle weakness varies widely between patients, as does the risk of myasthenic crisis, which is a severe and potentially fatal condition characterized by respiratory insufficiency requiring intensive care and mechanical ventilation. There is growing knowledge on comorbidities in patients with MG [1], e.g. increased risk of other autoimmune conditions, especially in patients with early-onset disease (EOMG) [2,3], increased risk of cardiovascular disorders in patients with late-onset disease (LOMG) [4] and increased risk of extra-thymic cancers in patients with thymoma-associated MG (TAMG) [5,6].
Source: Neuromuscular Disorders - Category: Neurology Authors: Elisabet Westerberg, Anna Rostedt Punga Source Type: research
More News: Autoimmune Disease | Brain | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Intensive Care | Myasthenia Gravis | Neurology | Respiratory Medicine | Sweden Health